Literature DB >> 30737607

Prevalence and current therapy in chronic liver disorders.

Muhammad Daniyal1, Muhammad Akram2, Rida Zainab3, Naveed Munir4, Aamir Sharif5, Syed Muhammad Ali Shah2, Bin Liu6, Wei Wang1.   

Abstract

BACKGROUND: Herbal medicine plays an important role in health, particularly in remote parts of developing areas with few health facilities. According to WHO estimates, about three-quarters of the world's population currently use herbs or traditional medicines to treat various ailments, including liver diseases. Several studies have found that the use of medicinal plants was effective in the treatment of infectious and non-infectious diseases. Hepatitis and liver cirrhosis associated with many clinical manifestations can be treated with allopathic medicines, but reports of a number of side effects including immunosuppression, bone marrow suppression, and renal complications have motivated researchers to explore more natural herbal medicines with low or no side effects and with high efficacy in treating hepatic diseases.
METHODS: Databases including PubMed, Medline, and Google Scholar were searched for findings on the hepatoprotective effects of plants.
RESULTS: Various medicinal plants are used for the treatment of liver disorders. The range of alternative therapies is huge, and they are used worldwide, either as part of primary health care or in combination with conventional medicine. Hepatoprotective plants contain a variety of chemical constituents including flavonoids, alkaloids, glycosides, carotenoids, coumarins, phenols, essential oil, organic acids, monoterpenes, xanthenes, lignans, and lipids.
CONCLUSION: This review shows that numerous plants are found to contain hepatoprotective compounds. However, further studies are needed to determine their association with existing regimes of antiviral medicines and to develop evidence-based alternative medicine to cure different kinds of liver disease in humans.

Entities:  

Keywords:  Allopathic medicine; Efficacy; Hepatoprotective activity; Literature review; Liver disorders; Medicinal plants; Side effects

Mesh:

Substances:

Year:  2019        PMID: 30737607     DOI: 10.1007/s10787-019-00562-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  122 in total

1.  The cost of hepatitis A infections in American adolescents and adults in 1997.

Authors:  J J Berge; D P Drennan; R J Jacobs; A Jakins; A S Meyerhoff; W Stubblefield; M Weinberg
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

2.  Anti-hepatotoxic effects of root and root callus extracts of Cichorium intybus L.

Authors:  R Zafar; S Mujahid Ali
Journal:  J Ethnopharmacol       Date:  1998-12       Impact factor: 4.360

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Hepatoprotective effects of Arctium lappa on carbon tetrachloride- and acetaminophen-induced liver damage.

Authors:  S C Lin; T C Chung; C C Lin; T H Ueng; Y H Lin; S Y Lin; L Y Wang
Journal:  Am J Chin Med       Date:  2000       Impact factor: 4.667

5.  [Mechanism of protective action of Phyllanthus urinaria L. against injuries of liver cells].

Authors:  S Zhou; C Xu; N Zhou; Y Huang; L Huang; X Chen; Y Hu; Y Liao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1997-02

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

7.  Treatment of chronic liver diseases with traditional Chinese medicine.

Authors:  B E Wang
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

8.  Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus.

Authors:  A U Neumann; N P Lam; H Dahari; M Davidian; T E Wiley; B P Mika; A S Perelson; T J Layden
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

9.  Nardostachys jatamansi protects against liver damage induced by thioacetamide in rats.

Authors:  S Ali; K A Ansari; M A Jafry; H Kabeer; G Diwakar
Journal:  J Ethnopharmacol       Date:  2000-08       Impact factor: 4.360

10.  Euphane triterpenoid and lipid constituents from Butea monosperma.

Authors:  M Mishra; Y N Shukla; S Kumar
Journal:  Phytochemistry       Date:  2000-08       Impact factor: 4.072

View more
  4 in total

Review 1.  Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?

Authors:  Yau-Tuen Chan; Ning Wang; Hor Yue Tan; Sha Li; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

2.  Growth Performance, Histological Changes and Functional Tests of Broiler Chickens Fed Diets Supplemented with Tribulus Terrestris Powder.

Authors:  Maged A Al-Garadi; Hani H Al-Baadani; Abdulmohsen H Alqhtani
Journal:  Animals (Basel)       Date:  2022-07-28       Impact factor: 3.231

Review 3.  Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis.

Authors:  Wen-Qing Li; Wen-Hao Liu; Die Qian; Jia Liu; Shi-Qiong Zhou; Lei Zhang; Wei Peng; Li Su; Hong Zhang
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

Review 4.  A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications.

Authors:  Min Wen; Qi Chen; Wang Chen; Jing Yang; Xiaogang Zhou; Chunxiang Zhang; Anguo Wu; Jia Lai; Jianping Chen; Qibing Mei; Shuo Yang; Cai Lan; Jianming Wu; Feihong Huang; Long Wang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.